Polysaccharide Engineered Nanozymes Target Inflammation for Alleviating Colitis‐Associated Mental Disorders via Microbiome‐Gut–Brain Axis
Advanced Materials · 2026-03 · 38 (14)
DOI: 10.1002/adma.202522010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 01.02.2026. Verfasst von Gen Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Faculty of Medicine, Yangzhou University, Yangzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Polysaccharides, Brain, Colitis, Gastrointestinal Microbiome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Yangzhou "Lvyang Jinfeng" Talent Program.
Abstract (Originalsprache)
Molecular therapies for colitis‐associated mental disorders show limited efficacy because they usually focus on a single pathway and exhibit substantial off‐target toxicity toward healthy tissues. To tackle this limitation, bioinformatic approaches are employed to predict that inflammation and metabolism may be potential targets for Fucoidan. Guided by this prediction, we develop oral polysaccharide engineered nanozymes, Fucoidan‐cerium nanocomplexes (FucCeNCs), which are capable of targeting the inflamed colon through electrostatic interactions, exerting anti‐inflammatory effects, and concurrently regulating gut microbiota‐derived metabolism. In a murine model of ulcerative colitis‐associated mental disorders, FucCeNCs show anti‐inflammatory and gut barrier‐protective effects, thereby suppressing microglial/astrocytic overactivation and preserving neuronal integrity through the transmission of anti‐inflammatory cytokines via gut–brain axis. Importantly, FucCeNCs restore gut microbial homeostasis through increasing the relative abundance of probiotics and reducing proportions of pathogens. This shift results in a marked attenuation of abnormal amino acid biosynthesis and metabolism in fecal metabolites, which in turn leads to elevated levels of bioactive metabolites such as homovanillic acid and γ‐aminobutyric acid. These metabolites ultimately attenuate neuroinflammation via the microbiome‐gut–brain axis, ameliorating depression‐ and anxiety‐like behaviors. These results identify microbiome‐gut–brain axis as pivotal therapeutic target for colitis‐associated mental disorders therapy, which can be addressed by polysaccharide engineered nanozymes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Traditional Chinese Medicine, Faculty of Medicine, Yangzhou University, Yangzhou, Jiangsu, China.
- Key Laboratory of the Jiangsu Higher Education Institutions for Integrated Traditional Chinese and Western Medicine in Senile Diseases Control (Yangzhou University), Yangzhou, Jiangsu, China.
- Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, China.
- School of Chemistry & Materials, Yangzhou University, Yangzhou, Jiangsu, China.
- Department of Biomedical Engineering, College of Engineering and Applied Sciences, Nanjing National Laboratory of Microstructures, Jiangsu Key Laboratory of Artificial Functional Materials, Nanjing University, Nanjing,…
ORCID-Profile: Hui Wei
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Yangzhou "Lvyang Jinfeng" Talent Program
- Yangzhou Key Research, Development Program (Social Development)
- China Postdoctoral Science Foundation
- Natural Science Foundation of Jiangsu Higher Education Institution
- Natural Science Foundation of Yangzhou Municipality
Zitieren
APA
Wei, G., Zhang, H., Zhao, S., Jiang, J., Liu, C., Li, P., Ni, Y., Dai, H., Fan, L., Wei, H., & Xi, J. (2026). Polysaccharide Engineered Nanozymes Target Inflammation for Alleviating Colitis‐Associated Mental Disorders via Microbiome‐Gut–Brain Axis. Advanced Materials, 38(14). https://doi.org/10.1002/adma.202522010
Vancouver
Wei G, Zhang H, Zhao S, Jiang J, Liu C, Li P, et al. Polysaccharide Engineered Nanozymes Target Inflammation for Alleviating Colitis‐Associated Mental Disorders via Microbiome‐Gut–Brain Axis. Advanced Materials. 2026;38(14). doi:10.1002/adma.202522010
BibTeX
@article{Wei2026,
author = {Wei, Gen and Zhang, Hui and Zhao, Shuang and Jiang, Jian and Liu, Chen and Li, Peng and Ni, Yaya and Dai, Hua and Fan, Lei and Wei, Hui and Xi, Juqun},
title = {Polysaccharide Engineered Nanozymes Target Inflammation for Alleviating Colitis‐Associated Mental Disorders via Microbiome‐Gut–Brain Axis},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {14},
doi = {10.1002/adma.202522010}
}
EUVIMED